Quick Dispatch:
Your glp-1 prostate cancer GLP-1 Receptor Agonists in Solid Tumour Therapy: Exploring Their Anticancer Potential and Underlying Molecular Pathways orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your glp-1 prostate cancer GLP-1 Receptor Agonists in Solid Tumour Therapy: Exploring Their Anticancer Potential and Underlying Molecular Pathways ships.
Need Help?
Questions about glp-1 prostate cancer GLP-1 Receptor Agonists in Solid Tumour Therapy: Exploring Their Anticancer Potential and Underlying Molecular Pathways, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for glp-1 prostate cancer GLP-1 Receptor Agonists in Solid Tumour Therapy: Exploring Their Anticancer Potential and Underlying Molecular Pathways in your area.
Glucagon-like peptide-1 medicines and cancer
21.72
The GLP-1 receptor is expressed in vivo by human metastatic prostate cancer in: Endocrine Oncology Volume 4 Issue 1 (2024)
29.21
Frontiers
27.27
Unlocking the multifaceted roles of GLP-1: Physiological functions and therapeutic potential
29.67
Depicts Mechanisms of Prostate Cancer Prevention by GLP-1RAs. GLP-1RA:
25.72
GLP-1 Agonists: Dual Benefits for Diabetes and Cancer
21.12
GLP-1 drugs linked to major slowdown in cancer spread, new study finds
21.55
